Julie Ann Dopheide, PharmD

Title(s)Professor of Clinical Pharmacy
SchoolUSC School of Pharmacy
AddressPSC 602
Health Sciences Campus
Los Angeles CA 90089-9121
Phone+1 323 442 1454
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Research Interest
    Dr. Dopheide's work focuses on clinical research involving inpatients with psychiatric illness and expanding roles for psychiatric pharmacists in primary care settings. She has investigated the tolerability of Depakote loading in patients with bipolar disorder and has examined the use of psychotropic medications in hospitalized persons with eating disorders. Dr. Dopheide has collaborated with her PGY-2 psychiatric pharmacy residents to demonstrate the value of integrating psychiatric pharmacists into the medical home to provide comprehensive medication management for patients with both psychiatric and medical conditions.

    Dr. Dopheide has published over 40 articles in peer-reviewed journals, textbooks and educational publications, on topics including ADHD, depression, sleep, insomnia and drug-induced psychiatric disorders.

    Dr. Dopheide is a Professor of Clinical Pharmacy, Psychiatry and the Behavioral Sciences at the University of Southern California School of Pharmacy, and Keck School of Medicine. She is actively involved in teaching pharmacy students, medical students and psychiatry and pharmacy residents through didactic and clinical teaching.

    Dr. Dopheide’s clinical practice is divided between adults, adolescents and children with psychiatric illness. She serves on Los Angeles County’s department of mental health pediatric psychotropic guideline development committee. As part of a multidisciplinary treatment team, Dr. Dopheide makes recommendations to optimize treatment for psychiatric illnesses including schizophrenia, mood disorders, anxiety, attention-deficit hyperactivity disorder, chronic insomnia and substance abuse.

    Dr. Dopheide is the immediate past president of the College of Psychiatric and Neurologic Pharmacists (CPNP). She is also actively involved with the American Society of Health System Pharmacist’s (ASHP), the American Pharmacists Association, and the National Alliance of the Mentally (NAMI). She is the PGY2 psychiatric pharmacy residency program director and supervises the resident in providing medication therapy management for outpatients in the Center for Community Health safety net clinic located in downtown Los Angeles.

    Dr. Dopheide obtained her PharmD from the University of Nebraska College of Pharmacy in Omaha and went on to complete a residency in Psychiatric Pharmacy Practice at the University of Southern California Medical Center. She has over 40 publications on topics in psychopharmacology and clinical pharmacy. A Nebraska native, she now considers Southern California her home and enjoys rooting for both the Cornhuskers and the Trojans during football season.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Therapeutic Drug Level Monitoring of Antipsychotics at an Inpatient Psychiatric Hospital. Ther Drug Monit. 2024 Apr 01; 46(2):210-216. Bhavsar NC, Dopheide JA, Botello TE, Wang M. PMID: 38018824.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. The mental health workforce needs pharmacists. Am J Health Syst Pharm. 2023 11 22; 80(23):1752-1758. Dopheide JA, Onyema IE, Casey T, Goodwin H, Moore TD, Payne GH. PMID: 37659002.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Best practices for documentation of psychotropic drug-drug interactions in an adult psychiatric clinic. Ment Health Clin. 2023 Feb; 13(1):11-17. Collins K, Dopheide JA, Wang M, Keshishian T. PMID: 36891479; PMCID: PMC9987259.
      View in: PubMed   Mentions:
    4. Antipsychotic Safety in Liver Disease: A Narrative Review and Practical Guide for the Clinician. J Acad Consult Liaison Psychiatry. 2023 Jan-Feb; 64(1):73-82. Gunther M, Dopheide JA. PMID: 36180017.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    5. Changing manufacturer to address neutropenia induced by non-clozapine second-generation antipsychotics: Changing antipsychotic manufacturer to address neutropenia. J Am Pharm Assoc (2003). 2022 Jul-Aug; 62(4):1441-1445. Kim HI, Dopheide JA. PMID: 35527208.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Positioning psychiatric pharmacists to improve mental health care. Ment Health Clin. 2022 Apr; 12(2):77-85. Dopheide JA, Werremeyer A, Haight RJ, Gutierrez CA, Williams AM. PMID: 35582321; PMCID: PMC9009818.
      View in: PubMed   Mentions: 5  
    7. Factors influencing performance on the Board Certified Psychiatric Pharmacist Examination: Passing rates and domain-level scores. Ment Health Clin. 2021 Nov; 11(6):358-364. Muckle TJ, Dopheide J, Gable K, Meng Y, Johnson SG, Ellis W. PMID: 34824960; PMCID: PMC8582766.
      View in: PubMed   Mentions:
    8. Collaboration Between Child and Adolescent Psychiatrists and Mental Health Pharmacists to Improve Treatment Outcomes. Child Adolesc Psychiatr Clin N Am. 2021 10; 30(4):797-808. Lu DH, Dopheide JA, Wang D, Jeffrey JK, Chen S. PMID: 34538449.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    9. Pharmacists: Essential partners in shared decision-making for schizophrenia and schizoaffective disorder. Am J Health Syst Pharm. 2020 12 04; 77(24):2023-2024. Dopheide JA. PMID: 33274742.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. Insomnia overview: epidemiology, pathophysiology, diagnosis and monitoring, and nonpharmacologic therapy. Am J Manag Care. 2020 03; 26(4 Suppl):S76-S84. Dopheide JA. PMID: 32282177.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    11. Do pharmacist employers prefer or require board certification? J Am Pharm Assoc (2003). 2020 Jan - Feb; 60(1):66-71.e1. Goldenshteyn F, Dopheide J, Lou M. PMID: 31740294.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Pharmacy resident teaching in psychiatry and neurology for pharmacy programs in the United States. Ment Health Clin. 2018 Jul; 8(4):163-168. Cho VM, Dopheide JA. PMID: 30155390; PMCID: PMC6063455.
      View in: PubMed   Mentions:
    13. Curriculum in Psychiatry and Neurology for Pharmacy Programs. Am J Pharm Educ. 2017 Sep; 81(7):5925. Dopheide JA, Bostwick JR, Goldstone LW, Thomas K, Nemire R, Gable KN, Cates M, Caballero J, Smith T, Bainbridge J. PMID: 29109559; PMCID: PMC5663650.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    14. Antipsychotic Selection for Acute Agitation and Time to Repeat Use in a Psychiatric Emergency Department. J Psychiatr Pract. 2016 11; 22(6):450-458. Gomez S, Dopheide J. PMID: 27824777.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    15. Acetylcysteine for treatment of autism spectrum disorder symptoms. Am J Health Syst Pharm. 2015 Nov 15; 72(22):1956-9. Stutzman D, Dopheide J. PMID: 26541950.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    16. Nonpsychiatric medication interventions initiated by a postgraduate year 2 psychiatric pharmacy resident in a patient-centered medical home. Prim Care Companion CNS Disord. 2014; 16(6). Williams AM, Dopheide JA. PMID: 25834765; PMCID: PMC4374824.
      View in: PubMed   Mentions: 3     Fields:    
    17. Psychiatric pharmacist management of depression in patients with diabetes. Prim Care Companion CNS Disord. 2013; 15(5). Nazarian PK, Dopheide JA. PMID: 24511443; PMCID: PMC3907323.
      View in: PubMed   Mentions: 4     Fields:    
    18. Vilazodone's comparative merits yet to be demonstrated. Am J Health Syst Pharm. 2012 Sep 15; 69(18):1549. Dopheide JA. PMID: 22935936.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    19. Role of a psychiatric pharmacist in a Los Angeles "Skid-Row" safety-net clinic. J Urban Health. 2011 Aug; 88(4):718-23. Wang I, Dopheide JA, Gregerson P. PMID: 21512832; PMCID: PMC3157501.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    20. Psychiatric pharmacist and primary care collaboration at a skid-row safety-net clinic. J Natl Med Assoc. 2011 Jul; 103(7):567-74. Chung B, Dopheide JA, Gregerson P. PMID: 21999031.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    21. Iloperidone: Does it have a meaningful place in therapy? Am J Health Syst Pharm. 2011 Feb 15; 68(4):297. Dopheide JA. PMID: 21289322.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. Attention-deficit-hyperactivity disorder: an update. Pharmacotherapy. 2009 Jun; 29(6):656-79. Dopheide JA, Pliszka SR. PMID: 19476419.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    23. The role of pharmacotherapy and managed care pharmacy interventions in the treatment of ADHD. Am J Manag Care. 2009 May; 15(5 Suppl):S141-50. Dopheide JA. PMID: 19601689.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    24. Paliperidone: An improvement over risperidone? Am J Health Syst Pharm. 2008 Mar 01; 65(5):401. Dopheide JA. PMID: 18281730.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Depression screening in a university campus pharmacy: a pilot project. J Am Pharm Assoc (2003). 2006 Jul-Aug; 46(4):502-6. Knox ED, Dopheide JA, Wincor MZ, Han PK. PMID: 16913394.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    26. Recognizing and treating depression in children and adolescents. Am J Health Syst Pharm. 2006 Feb 01; 63(3):233-43. Dopheide JA. PMID: 16434782.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    27. Psychotropic medication use at a private eating disorders treatment facility: A retrospective chart review and descriptive data analysis. Curr Ther Res Clin Exp. 2005 Nov; 66(6):572-88. Gable KN, Dopheide JA. PMID: 24764595; PMCID: PMC3997119.
      View in: PubMed   Mentions: 3     Fields:    
    28. ASHP therapeutic position statement on the appropriate use of medications in the treatment of attention-deficit/hyperactivity disorder in pediatric patients. Am J Health Syst Pharm. 2005 Jul 15; 62(14):1502-9. Dopheide JA. PMID: 15998933.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    29. Visual compatibility of risperidone solution and lithium citrate syrup. Am J Health Syst Pharm. 2003 Mar 15; 60(6):612-3. Park SH, Gill MA, Dopheide JA. PMID: 12659069.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. Developing a partnership with NAMI and psychiatric pharmacists. Schizophr Bull. 2002; 28(3):525-9. Roe KK, Dopheide JA, Wincor MZ. PMID: 12645683.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    31. A naturalistic comparison of adverse effects between slow titration and loading of divalproex sodium in psychiatric inpatients. J Affect Disord. 1999 Jan-Mar; 52(1-3):261-7. Lima WJ, Dopheide JA, Kramer BA, Earhart CA, Wincor MZ. PMID: 10357044.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    32. Gabapentin and lamotrigine in the treatment of bipolar disorder. J Am Pharm Assoc (Wash). 1998 Sep-Oct; 38(5):632-4. Dopheide JA, Wincor MZ. PMID: 9782699.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    33. Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects. Pharmacotherapy. 1997 Jan-Feb; 17(1):10-21. Stimmel GL, Dopheide JA, Stahl SM. PMID: 9017762.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    Julie's Networks
    Concepts (147)
    Derived automatically from this person's publications.
    Co-Authors (4)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department